US Patent 11479609 CD80 variant immunomodulatory proteins and uses thereof
Patent 11479609 was granted and assigned to ALPINE IMMUNE SCIENCES, INC. on October, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 2, 2022
0
Date of Patent
October 25, 2022
0
Patent Applicant
Patent Application Number
17591545
0
Patent Citations
Patent Inventor Names
Ryan Swanson
0
Michael Kornacker
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11479609 CD80 variant immunomodulatory proteins and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
